251 related articles for article (PubMed ID: 25660162)
1. Canakinumab for the treatment of chronic obstructive pulmonary disease.
Rogliani P; Calzetta L; Ora J; Matera MG
Pulm Pharmacol Ther; 2015 Apr; 31():15-27. PubMed ID: 25660162
[TBL] [Abstract][Full Text] [Related]
2. The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.
Satoh T; Otsuka A; Contassot E; French LE
Immunotherapy; 2015; 7(3):243-54. PubMed ID: 25804477
[TBL] [Abstract][Full Text] [Related]
3. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD.
Pauwels NS; Bracke KR; Dupont LL; Van Pottelberge GR; Provoost S; Vanden Berghe T; Vandenabeele P; Lambrecht BN; Joos GF; Brusselle GG
Eur Respir J; 2011 Nov; 38(5):1019-28. PubMed ID: 21622588
[TBL] [Abstract][Full Text] [Related]
4. Role of the inflammasome-caspase1/11-IL-1/18 axis in cigarette smoke driven airway inflammation: an insight into the pathogenesis of COPD.
Eltom S; Belvisi MG; Stevenson CS; Maher SA; Dubuis E; Fitzgerald KA; Birrell MA
PLoS One; 2014; 9(11):e112829. PubMed ID: 25405768
[TBL] [Abstract][Full Text] [Related]
5. The nucleotide-binding domain and leucine-rich repeat protein-3 inflammasome is not activated in airway smooth muscle upon toll-like receptor-2 ligation.
Hirota JA; Im H; Rahman MM; Rumzhum NN; Manetsch M; Pascoe CD; Bunge K; Alkhouri H; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):517-24. PubMed ID: 23614732
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
Zheng Q; Ren Y; Reinach PS; Xiao B; Lu H; Zhu Y; Qu J; Chen W
Exp Eye Res; 2015 May; 134():133-40. PubMed ID: 25701684
[TBL] [Abstract][Full Text] [Related]
7. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
8. Cytokine inhibition in the treatment of COPD.
Caramori G; Adcock IM; Di Stefano A; Chung KF
Int J Chron Obstruct Pulmon Dis; 2014; 9():397-412. PubMed ID: 24812504
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor dysfunction orchestrates inflammasome effects on chronic obstructive pulmonary disease-induced depression: A potential mechanism underlying the cross talk between lung and brain.
Deng X; Fu J; Song Y; Xu B; Ji Z; Guo Q; Ma S
Brain Behav Immun; 2019 Jul; 79():195-206. PubMed ID: 30738183
[TBL] [Abstract][Full Text] [Related]
10. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β.
Bracey NA; Beck PL; Muruve DA; Hirota SA; Guo J; Jabagi H; Wright JR; Macdonald JA; Lees-Miller JP; Roach D; Semeniuk LM; Duff HJ
Exp Physiol; 2013 Feb; 98(2):462-72. PubMed ID: 22848083
[TBL] [Abstract][Full Text] [Related]
11. Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders.
Church LD; McDermott MF
Curr Opin Mol Ther; 2009 Feb; 11(1):81-9. PubMed ID: 19169963
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.
Lappalainen U; Whitsett JA; Wert SE; Tichelaar JW; Bry K
Am J Respir Cell Mol Biol; 2005 Apr; 32(4):311-8. PubMed ID: 15668323
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.
Zheng Q; Ren Y; Reinach PS; She Y; Xiao B; Hua S; Qu J; Chen W
Exp Eye Res; 2014 Aug; 125():1-8. PubMed ID: 24836981
[TBL] [Abstract][Full Text] [Related]
14. Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta.
Rumora L; Hlapčić I; Popović-Grle S; Rako I; Rogić D; Čepelak I
PLoS One; 2020; 15(6):e0234363. PubMed ID: 32502184
[TBL] [Abstract][Full Text] [Related]
15. Applying caspase-1 inhibitors for inflammasome assays in human whole blood.
Lipinska K; Malone KE; Moerland M; Kluft C
J Immunol Methods; 2014 Sep; 411():66-9. PubMed ID: 24925806
[TBL] [Abstract][Full Text] [Related]
16. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
17. Chemical stimulation of the intracranial dura activates NALP3 inflammasome in trigeminal ganglia neurons.
Chen L; Li X; Huang L; Wu Q; Chen L; Wan Q
Brain Res; 2014 May; 1566():1-11. PubMed ID: 24769167
[TBL] [Abstract][Full Text] [Related]
18. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
19. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of inflammasome activation: recent advances and novel insights.
Vanaja SK; Rathinam VA; Fitzgerald KA
Trends Cell Biol; 2015 May; 25(5):308-15. PubMed ID: 25639489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
